Dernières publications scientifiques

  • Restrictive Versus A Liberal Transfusion Strategy in Patients With Spontaneous Intracerebral Hemorrhage: A Secondary Analysis of TRAIN Randomized Clinical Trial.

  • Auteurs Faso C, Gouvea Bogossian E, Bittencourt Rynkowski C, Moller K, Lormans P, Quintana Diaz M, Caricato A, Dabrowski W, Gonzalez Perez I, Steblaj S, Quintard H, Justo P, Righy C, Roman Pognuz E, Huet O, Mahmoodpoor A, Blandino-Ortiz A, Junttila E, Funes N, Izzo G, Zattera L, Giacomucci A, Dibu J, Rodrigues A, Bouzat P, Vincent JL, Taccone FS
  • Revue Stroke
  • Date de publication 2025-06
Restrictive Versus A Liberal Transfusion Strategy in Patients With Spontaneous Intracerebral Hemorrhage: A Secondary Analysis of TRAIN Randomized Clinical Trial.
  • Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data.

  • Auteurs Wittens MMJ, Sima DM, Brys A, Struyfs H, Niemantsverdriet E, De Roeck E, Bastin C, Benoit F, Bergmans B, Bier JC, de Deyn PP, Deryck O, Hanseeuw B, Ivanoiu A, Picard G, Salmon E, Segers K, Sieben A, Thiery E, Tournoy J, van Binst AM, Versijpt J, Smeets D, Bjerke M, Bellio M, Oxtoby NP, Alexander DC, Ribbens A, Engelborghs S
  • Revue Alzheimers Res Ther
  • Date de publication 2025-06
Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data.
  • Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

  • Auteurs Maertens JA, Thompson GR, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M, Morrissey CO, Mehta SR, Heath CH, Koehler P, Paterson DL, Slavin MA, Fortún J, Nguyen MH, Patterson TF, Uspenskaya O, Van de Veerdonk FL, Verweij PE, Aoun M, Georgala A, Alexander BD, Chayakulkeeree M, Mehra V, Miceli MH, Sikka MK, Solé A, Walsh TJ, Aguado JM, Holland SM, Moussa M, Rautemaa-Richardson R, Bazaz R, Schwartz S, Walsh SR, Plate M, Yehudai-Ofir D, Brüggemann RJ, Cornely OA, Ostrosky-Zeichner L, Vazquez JA, White PL, Cornelissen K, Ross GG, Fitton L, Dane A, Zinzi D, Rex JH, Chen SC
  • Revue Lancet Infect Dis
  • Date de publication 2025-06
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.
Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasme

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Voir toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola